Aclaris Therapeutics (ACRS) Preferred Dividend Payments (2014 - 2015)
Aclaris Therapeutics (ACRS) posted quarterly Preferred Dividend Payments of $1.0 million for Q3 2015, up 112.94% year-over-year from $479000.0 in Q3 2014, and up 50.89% quarter-over-quarter from $676000.0 in Q2 2015.
Powered by 
Analysis
Aclaris Therapeutics (ACRS) Preferred Dividend Payments (2014 - 2015) Analysis & Trends
Aclaris Therapeutics' Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $1.0 million for Q3 2015.
- In Q3 2015, Preferred Dividend Payments rose 112.94% year-over-year to $1.0 million; the TTM figure through Dec 2015 stood at $2.4 million (changed N/A YoY), while the FY2015 annual figure was $1.8 million, down 14.12% from the prior year.
- Preferred Dividend Payments for Q3 2015 stood at $1.0 million, up from $676000.0 in the prior quarter.
- The five-year high for Preferred Dividend Payments was $1.0 million in Q3 2015, with the low at $479000.0 in Q3 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Aclaris Therapeutics | 882.83 Mn | 882.83 Mn | 1.41 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2015 | 213,000.00 |
| Sep 30, 2015 | 1.02 Mn |
| Jun 30, 2015 | 676,000.00 |
| Mar 31, 2015 | 657,000.00 |
| Dec 31, 2014 | 660,000.00 |
| Sep 30, 2014 | 479,000.00 |